© Alexey Novikov


Dive Brief:

– UPS is taking the infrastructure and experience it has gained from distributing the COVID-19 vaccine to offer a permanent cold chain solution through its healthcare division that’s focused on the transport of pharmaceutical, temperature-sensitive reagents and other medical-related cargo, the logistics provider announced this week.

– The company is pitching UPS Cold Chain Solutions as end-to-end transportation, where UPS takes care of storage, logistics and freight, all while tracking temperature diversions from command centers in Louisville, Kentucky, and Amsterdam.

– The company realized this type of service was needed in the healthcare space as its subsidiary, Marken, worked with pharmaceutical manufacturers for the clinical trials of the COVID-19 vaccine, according to Dan Gagnon, vice president for global healthcare marketing and strategy at UPS. “We began to see as a company what was going to happen,” Gagnon said. “We saw the innovation in vaccines; we saw that there [were] new vaccines that were coming out that required frozen storage and frozen transportation.”

Dive Insight:

The cold chain for the COVID-19 vaccine was notoriously fickle. This was especially true of the Pfizer vaccine, which required the use of a specially designed insulated box with dry ice inside to keep the temperature at minus 70 degrees Celsius for up to 10 days

To read the full post, please click here.

Comment on this article

You must be logged in to post a comment.